PURE Bioscience, Inc. (OTCMKTS:PURE) Sees Large Increase in Short Interest

PURE Bioscience, Inc. (OTCMKTS:PURE) was the target of a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 36,200 shares, an increase of 1,710.0% from the January 31st total of 2,000 shares. Based on an average daily volume of 35,300 shares, the days-to-cover ratio is presently 1.0 days.

PURE Bioscience Stock Down 4.8 %

Shares of OTCMKTS PURE opened at $0.06 on Friday. The company’s 50-day simple moving average is $0.07 and its 200-day simple moving average is $0.08. PURE Bioscience has a 52-week low of $0.06 and a 52-week high of $0.16. The firm has a market cap of $6.71 million, a price-to-earnings ratio of -1.50 and a beta of 0.13.

PURE Bioscience (OTCMKTS:PURE) last announced its earnings results on Monday, December 16th. The company reported ($0.01) earnings per share (EPS) for the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.